Arvast 10/Arvast 20

Arvast 10/Arvast 20



Accord Healthcare


Concise Prescribing Info
Rosuvastatin Ca
Treatment of adults, adolescents & childn ≥10 yr w/ primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as adjunct to diet when response to diet & other non-pharmacological treatments is inadequate. Homozygous familial hypercholesterolaemia as adjunct to diet & other lipid lowering treatments (eg, LDL apheresis). Prevention of major CV events.
Dosage/Direction for Use
Treatment of hypercholesterolaemia Statin naive & patient switched from another HMG CoA reductase inhibitor Initially 5 or 10 mg once daily. May adjust dose to next level after 4 wk. Max dose of 40 mg should only be considered in patients w/ severe hypercholesterolaemia at high CV risk (particularly those w/ familial hypercholesterolaemia), who do not achieve the treatment goal on 20 mg & whom routine follow-up will be performed. Prevention of CV events 20 mg once daily. Childn & adolescent w/ heterozygous familial hypercholesterolaemia Initially 5 mg daily. Usual dose range: 5-20 mg once daily. Elderly >70 yr, Asian, patient w/ predisposing factors to myopathy, moderate renal impairment (CrCl <60 mL/min) 5 mg.
May be taken with or without food.
Hypersensitivity. Patients w/ active liver disease including unexplained, persistent elevations of serum transaminases & any serum transaminase elevation exceeding 3 x the ULN; myopathy; receiving concomitant ciclosporin; severe renal impairment (CrCl <30 mL/min). Women of childbearing potential, pregnancy & lactation.
Special Precautions
Proteinuria in higher doses particularly 40 mg. Effects on skeletal muscle eg, myalgia, myopathy & rhabdomyolysis. Patients w/ pre-disposing factors for myopathy/rhabdomyolysis: Renal impairment, hypothyroidism, personal or family history of hereditary muscular disorders, previous history of muscular toxicity w/ another H MG-CoA reductase inhibitor or fibrate, alcohol abuse, age >70 yr, situations where an increase in plasma levels may occur, concomitant use of fibrates. If creatinine kinase levels are significantly elevated at baseline (>5 x ULN) treatment should not be started. Not recommended in concomitant w/ fibric acid derivatives including gemfibrozil, ciclosporin, nicotinic acid, azole antifungals, protease inhibitors & macrolides. Do not use in any patient w/ acute, serious condition suggestive of myopathy or predisposing to the development of renal failure secondary to rhabdomyolysis (eg, sepsis, hypotension, major surgery, trauma, severe metabolic, endocrine & electrolyte disorders; or uncontrolled seizures). Patients who consume excessive quantities of alcohol &/or have a history of liver disease; secondary hypercholesterolaemia caused by hypothyroidism or nephrotic syndrome. Increased exposure in Asian patients. Galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Interstitial lung disease w/ long-term therapy. Patients at risk (fasting glucose 5.6-6.9 mmol/L, BMI >30 kg/m2, raised triglycerides, HTN). Childn <10 yr.
Adverse Reactions
DM, headache, dizziness, constipation, nausea, abdominal pain, myalgia, asthenia.
Drug Interactions
Increased risk of myopathy w/ transporter protein inhibitors including hepatic uptake transporter OATP1B1 & efflux transporter BCRP. Contraindicated in concomitant w/ ciclosporin. Increased exposure w/ protease inhibitors. Increased Cmax & AUC w/ gemfibrozil & other lipid-lowering products. Increased AUC w/ ezetimibe. Decreased plasma conc w/ antacid. Decreased AUC & Cmax w/ erythromycin. Increased INR w/ vit K antagonists (eg, warfarin or other coumarin anticoagulant). May increase AUC of ethinyl estradiol & norgestrel.
ATC Classification
C10AA07 - rosuvastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Arvast 20 FC tab 20 mg
Arvast 10 FC tab 10 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in